[1] “Computed medical imaging.
Nobel lecture,
December 8,
1979.” Hounsfield GN.
J Comput Assist Tomogr. 1980; 4(5):665-74.
[2] “The essential physics of medical imaging” Bushberg JT.,
Seibert JA.,
Leidholdt EM.,
et al.
2012; 3rd edition.
Philadelphia,
PA: Lippincott Williams & Wilkins.
[3] “Computed tomography: fundamentals,
system technology,
image quality,
applications” Kalender WA.
2011; 3rd edition Erlangen,
Germany: Publicis Publishing.
[4] “CYP17 polymorphism as a risk factor of tamoxifen-induced hepatic steatosis in breast cancer patients” Ohnishi T.,
Ogawa Y.,
Saibara T.,
Nishioka A.,
Kariya S.,
Fukumoto M.,
Onishi S.,
Yoshida S.
Oncol Rep.
2005; 13(3):485-9.
[5] “Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation”.
Buchman AL.,
Dubin MD.,
Moukarzel AA.,
Jenden DJ.,
Roch M.,
Rice KM.,
Gornbein J.,
Ament ME.
Hepatology.
1995; 22(5)1399-403.
[6] “Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.” Choi H,
Charnsangavej C,
Faria SC,
Macapinlac HA,
Burgess MA,
Patel SR,
Chen LL,
Podoloff DA,
Benjamin RS.
J Clin Oncol.
2007 May 1;25(13):1753-9.
[7] “A randomised double-blind study of the short-time treatment of obese patients with non-alcoholic fatty liver disease with ursodeoxycholic acid.” Santos VN.,
Lanzoni VP.,
Szejnfeld J.,
Shigueoka D.,
Parise ER.
Braz J Med Biol Res.
2003; 36(6):723-9.
[8] “Evaluation of liver iron content by computed tomography: its value in the follow-up of treatment in patients with idiopathic hemochromatosis” Roudot-Thoraval F.,
Halphen M.,
Larde D.,
Galliot M.,
Rymer JC.,
Galacteros F.,
Dhumeaux D.
Hepatology.
1983; 3(6):974-9.
[9] “Dual-energy CT of liver metastases in patients with uveal melanoma" Altenbernd J.,
Wetter A.,
Forsting M.,
Umutlu L.
European Journal of radiology Open 3.
2016:254-258.
[10] “Factors influencing quantitative CT measurements of solitary pulmonary nodules” Zerhouni EA.,
Spivey JF.,
Morgan RH.
et al.
J.
Comput.
Assist Tomogr 1982;6:1075-1087.
[11] “The unreliability of CT numbers as absolute values” Levi C.,
Gray JE.,
McCullough EC.,
et al..
AJR Am J Roentgenol.
1982; 139:443-7.
[12] “Variations in measured computed tomography number values” Faulkner K.,
Moores BM.
Radiography.
1985; 51:163-7.
[13] “Multi-detector row CT attenuation measurements: assessment of intra- and interscanner variability with an anthropomorphic body CT phantom” Birnbaum BA.,
Hindman N.,
Lee J.,
Babb JS.
Radiology.
2007; 242(1):109-119.
[14] “An electron density calibration phantom for CT-based treatment planning computers”.Constantinou C,
Harrington JC,
DeWerd LA.
Med Phys 1992;19:325-7.
[15] “CT Hounsfield numbers of soft tissues on unenhanced abdominal CT scans: variability between two different manufacturers’ MDCT scanners” Lamba R.,
McGahan JP.,
Corwin MT.,
et al.
American Journal of Roentgenology.
2014; 203(5):1013-1020.
[16] “Comparison of tissue characterization curves for different CT scanners: implication in proton therapy treatment planning” Cheng CW.,
Zhao L.,
Wolanski M.
et al.
Translational cancer research.
2012; 1(4):236-246.
[17] “Statistical methods for assessing agreement between two methods of clinical measurement” Bland JM,
Altman DG..
Lancet,
i,
1986:307-310.